Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 868 participants.

Also called NCT07519044

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 868 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07519044
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07519044. Randomized; double masking; primary purpose treatment. Start 2026-05-14 (actual); primary completion 2027-01-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Adjunctive GM1 to Mechanical Thrombectomy for Acute Anterior Circulation Large Vessel Occlusion
Acronym
IAT-GIANT
Condition
Stroke
Condition
Acute Ischemic Stroke
Intervention (Drug)
Intravenous GM1 Therapy
Intervention (Drug)
Placebo Therapy
Lead sponsor
Xuanwu Hospital, Beijing (class: other)

Record details

Record id
cardio:ct-nct07519044
Content hash
03fb65fca526a4273084fa05701cecfe051af2870bbee6d00d85eeef105963d2